Search results
Found 6792 matches for
Enara Bio, a start-up located in the University’s BioEsclator, has announced a strategic collaboration and licensing agreement with Boehringer Ingelheim, worth over €876M (£787M), to lead the discovery and validation of Dark Antigens to target lung and gastrointestinal cancers.
Oxford Medicine December 2020
Oxford Medicine December 2020
Oxford Medicine Spring Summer 2021
Oxford Medicine Spring Summer 2021
Oxford Medicine Summer 2022
Oxford Medicine Summer 2022
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Magazine - Winter 2023
Oxford Medicine Autumn Winter 2021
Oxford Medicine Autumn Winter 2021